Italia markets close in 5 hours 47 minutes

Sunshine Biopharma, Inc. (SBFM)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
0,9900-0,0400 (-3,88%)
Alla chiusura: 04:00PM EDT
0,9598 -0,03 (-3,05%)
Preborsa: 05:19AM EDT
Schermo intero
Caricamento grafico interattivo in corso...
  • GlobeNewswire

    Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

    MONTREAL, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its quarterly report for the 2023 second quarter. The Company reported gross revenues of $5,560,865 for the quarter ended June 30, 2023, an increase of 3,600% over the same period in 2022. The increase was largely due to the

  • GlobeNewswire

    Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

    MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today closed its previously announced private placement pursuant to a securities purchase agreement with a single healthcare-focused institutional investor for gross proceeds of approximately $5 million, before deducting fees to the placement agent and other offering expens

  • GlobeNewswire

    Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

    MONTREAL, May 12, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced that it entered into a securities purchase agreement with a single healthcare-focused institutional investor for aggregate gross proceeds of approximately $5 million, before deducting fees to the placement agent and other offering expenses payable by the Com